Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Malignant Lymphoma

  Free Subscription


Articles published in Proc Natl Acad Sci U S A

Retrieve available abstracts of 24 articles:
HTML format
Text format



Single Articles


    October 2017
  1. DUCKER GS, Ghergurovich JM, Mainolfi N, Suri V, et al
    Human SHMT inhibitors reveal defective glycine import as a targetable metabolic vulnerability of diffuse large B-cell lymphoma.
    Proc Natl Acad Sci U S A. 2017;114:11404-11409.
    PubMed     Text format     Abstract available


    August 2017
  2. TANG J, Salloum D, Carney B, Brand C, et al
    Targeted PET imaging strategy to differentiate malignant from inflamed lymph nodes in diffuse large B-cell lymphoma.
    Proc Natl Acad Sci U S A. 2017 Aug 21. pii: 201705013.
    PubMed     Text format     Abstract available


    April 2017
  3. FISH K, Longnecker R
    EBV germinates lymphoma from the germinal center in a battle with T and NK cells.
    Proc Natl Acad Sci U S A. 2017 Apr 25. pii: 201704102.
    PubMed     Text format    


    March 2017
  4. CHEN J, Zhang Y, Petrus MN, Xiao W, et al
    Cytokine receptor signaling is required for the survival of ALK- anaplastic large cell lymphoma, even in the presence of JAK1/STAT3 mutations.
    Proc Natl Acad Sci U S A. 2017 Mar 29. pii: 201700682.
    PubMed     Text format     Abstract available


    December 2016
  5. LEMONNIER F, Cairns RA, Inoue S, Li WY, et al
    The IDH2 R172K mutation associated with angioimmunoblastic T-cell lymphoma produces 2HG in T cells and impacts lymphoid development.
    Proc Natl Acad Sci U S A. 2016 Dec 12. pii: 201617929.
    PubMed     Text format     Abstract available


  6. MUKHOPADHYAY C, Triplett A, Bargar T, Heckman C, et al
    Casitas B-cell lymphoma (Cbl) proteins protect mammary epithelial cells from proteotoxicity of active c-Src accumulation.
    Proc Natl Acad Sci U S A. 2016 Dec 5. pii: 201615677.
    PubMed     Text format     Abstract available


    October 2016
  7. CARROLL VA, Lafferty MK, Marchionni L, Bryant JL, et al
    Expression of HIV-1 matrix protein p17 and association with B-cell lymphoma in HIV-1 transgenic mice.
    Proc Natl Acad Sci U S A. 2016 Oct 31. pii: 201615258.
    PubMed     Text format     Abstract available


  8. RUI L, Drennan AC, Ceribelli M, Zhu F, et al
    Epigenetic gene regulation by Janus kinase 1 in diffuse large B-cell lymphoma.
    Proc Natl Acad Sci U S A. 2016 Oct 31. pii: 201610970.
    PubMed     Text format     Abstract available


    May 2016
  9. CORSO J, Pan KT, Walter R, Doebele C, et al
    Elucidation of tonic and activated B-cell receptor signaling in Burkitt's lymphoma provides insights into regulation of cell survival.
    Proc Natl Acad Sci U S A. 2016 May 6. pii: 201601053.
    PubMed     Text format     Abstract available


    April 2016
  10. TORCHIA J, Weiskopf K, Levy R
    Targeting lymphoma with precision using semisynthetic anti-idiotype peptibodies.
    Proc Natl Acad Sci U S A. 2016 Apr 25. pii: 201603335.
    PubMed     Text format     Abstract available



  11. Correction for Lee et al., Effects of lymphocyte profile on development of EBV-induced lymphoma subtypes in humanized mice.
    Proc Natl Acad Sci U S A. 2016 Apr 18. pii: 201605284.
    PubMed     Text format    


  12. HODSON DJ, Shaffer AL, Xiao W, Wright GW, et al
    Regulation of normal B-cell differentiation and malignant B-cell survival by OCT2.
    Proc Natl Acad Sci U S A. 2016;113:E2039-46.
    PubMed     Text format     Abstract available


    February 2016
  13. DOOSE G, Hoffmann S, Iaccarino I
    Reply to Hart et al.: MINCR and MYC: More than expression correlation.
    Proc Natl Acad Sci U S A. 2016;113:E498.
    PubMed     Text format    


    January 2016
  14. MAMBETSARIEV N, Lin WW, Stunz LL, Hanson BM, et al
    Nuclear TRAF3 is a negative regulator of CREB in B cells.
    Proc Natl Acad Sci U S A. 2016;113:1032-7.
    PubMed     Text format     Abstract available


  15. JU W, Zhang M, Wilson KM, Petrus MN, et al
    Augmented efficacy of brentuximab vedotin combined with ruxolitinib and/or Navitoclax in a murine model of human Hodgkin's lymphoma.
    Proc Natl Acad Sci U S A. 2016 Jan 25. pii: 201524668.
    PubMed     Text format     Abstract available


  16. HART JR, Weinberg MS, Morris KV, Roberts TC, et al
    MINCR is not a MYC-induced lncRNA.
    Proc Natl Acad Sci U S A. 2016 Jan 25. pii: 201519903.
    PubMed     Text format    


  17. DEKKER JD, Park D, Shaffer AL 3rd, Kohlhammer H, et al
    Subtype-specific addiction of the activated B-cell subset of diffuse large B-cell lymphoma to FOXP1.
    Proc Natl Acad Sci U S A. 2016 Jan 19. pii: 201524677.
    PubMed     Text format     Abstract available


  18. WEINSTEIN S, Toker IA, Emmanuel R, Ramishetti S, et al
    Harnessing RNAi-based nanomedicines for therapeutic gene silencing in B-cell malignancies.
    Proc Natl Acad Sci U S A. 2016;113:E16-22.
    PubMed     Text format     Abstract available


  19. WEISSMANN M, Arvatz G, Horowitz N, Feld S, et al
    Heparanase-neutralizing antibodies attenuate lymphoma tumor growth and metastasis.
    Proc Natl Acad Sci U S A. 2016 Jan 4. pii: 201519453.
    PubMed     Text format     Abstract available


    November 2015

  20. Correction to Supporting Information for Dolcetti et al., Role of HIV-1 matrix protein p17 variants in lymphoma pathogenesis.
    Proc Natl Acad Sci U S A. 2015 Nov 30. pii: 201522501.
    PubMed     Text format    


  21. DOLCETTI R, Giagulli C, He W, Selleri M, et al
    Role of HIV-1 matrix protein p17 variants in lymphoma pathogenesis.
    Proc Natl Acad Sci U S A. 2015;112:14331-14336.
    PubMed     Text format     Abstract available


  22. VITRE B, Holland AJ, Kulukian A, Shoshani O, et al
    Chronic centrosome amplification without tumorigenesis.
    Proc Natl Acad Sci U S A. 2015;112:E6321-30.
    PubMed     Text format     Abstract available


    October 2015
  23. NEELAPU SS, Sharma P
    Targeting the tumor niche to treat cancer.
    Proc Natl Acad Sci U S A. 2015;112:12907-8.
    PubMed     Text format    


    August 2015
  24. LIN CW, Tsai MH, Li ST, Tsai TI, et al
    A common glycan structure on immunoglobulin G for enhancement of effector functions.
    Proc Natl Acad Sci U S A. 2015;112:10611-6.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: